PROBLEM TO BE SOLVED: To provide compounds that can be specific to peroxisome proliferation factor activation (PPAR) and/or EGF receptors.SOLUTION: This invention relates to compounds represented by formula (1), pharmaceutically acceptable salt or N-oxide thereof, where X is C1-3 alkylene, substituted/unsubstituted with 1-3 halogen or hydroxyl.COPYRIGHT: (C)2015,JPO&INPIT【課題】ペルオキシソーム増殖因子活性化(PPAR)受容体及び/又はEGF受容体に対して特異的であり得る化合物の提供。【解決手段】式(I)で表される化合物又はその薬学的に受容可能な塩或いはN-オキシド。(Xは1~3のハロゲン又はヒドロキシルで置換/非置換のC1~3のアルキレン)【選択図】なし